Tackles the challenge of illegal pre‑rolls and unregulated cannabis, emphasizing the importance of purchasing tested, compliant products.
Key sections to cover:
-
Scale of the illicit market: In New York, roughly 85 legal dispensaries competed with 1,400 + illicit outlets in early 2024, meaning many consumers still buy untested pre‑rolls.
-
Risks of untested products: Explain potential contamination, inconsistent potency and safety hazards; link back to quality control measures.
-
Consumer education: Encourage brands to communicate the benefits of lab‑tested, compliant products; highlight labeling requirements and child‑resistant packaging.
-
Competitive pricing and value: Discuss how multi‑packs and price reductions (16.7 % drop since 2023) make legal products more affordable, reducing the appeal of illicit goods.
Partnerships with dispensaries: Suggest collaborating with legal retailers on promotions, budtender education and social media campaigns to build trust.